Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhao, Wen H.-
dc.contributor.authorZhang, Li X.-
dc.contributor.authorLiu, Chan X.-
dc.contributor.authorNiedermann Schneider, Karin-
dc.contributor.authorYang, Han Z.-
dc.contributor.authorLuo, Wen-
dc.date.accessioned2019-12-19T10:38:10Z-
dc.date.available2019-12-19T10:38:10Z-
dc.date.issued2019-
dc.identifier.issn0770-3198de_CH
dc.identifier.issn1434-9949de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/18955-
dc.description.abstractOBJECTIVE: To develop and validate the Chinese version of the Joint Protection Self-Efficacy Scale (CJP-SES) in patients with rheumatoid arthritis (RA) in China. METHOD: (1) Translation of the original German/English version JP-SES and cultural adaptation into the Chinese language; (2)Validation of the CJP-SES with the Chinese versions of the Arthritis Self-Efficacy Scale-8 (ASES-8), the Laffrey Health Conception Scale (LHCS), 10-item Perceived Efficacy in Patient-Physician Interactions Scale (PEPPI-10), Disease Activity Score-28 (DAS-28) and Health Assessment Questionnaire (HAQ). Instrument measurement included reliability testing, item generation, construct validity, test-retest reliability, and correlation with other measurements. Confirmatory factor analysis was applied to determine construct validity and internal consistency. One hundred fifteen patients with RA were investigated. RESULT: Finally, 105 RA patients were included in the analysis. Confirmatory factor analysis demonstrated fit for a unidimensional model of the JP-SES. Additionally, the scale showed internal consistency (Cronbach's α coefficient 0.922), kappa coefficient (0.653), and test-retest reliability (ICC = 0.94). Weak correlations with other scores for the other instruments, such as the Chinese version of ASES-8 (0.263) and PEPPI-10 (0.326). Correlation with duration (0.274), moderate correlation with BMI (- 0.438) and DAS-28 (- 0.493), and strong correlation with HAQ (- 0.644) were found in this research. CONCLUSION: This is the first study to adapt and validate the JP-SES into Chinese for use in patients with RA. Our research showing that the CJP-SES has a good construct validity, internal consistency, and test-retest reliability. This scale can help doctors and nurses to assess the self-efficacy of patients with RA.de_CH
dc.language.isoende_CH
dc.publisherSpringerde_CH
dc.relation.ispartofClinical Rheumatologyde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectJoint protectionde_CH
dc.subjectRheumatoid arthritisde_CH
dc.subjectSelf-efficacyde_CH
dc.subjectValidationde_CH
dc.subject.ddc616.7: Krankheiten des Bewegungsapparates und Orthopädiede_CH
dc.titleValidation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritisde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementGesundheitde_CH
zhaw.organisationalunitInstitut für Physiotherapie (IPT)de_CH
dc.identifier.doi10.1007/s10067-019-04510-8de_CH
dc.identifier.pmid30972575de_CH
zhaw.funding.euNode_CH
zhaw.issue8de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end2127de_CH
zhaw.pages.start2119de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume38de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.author.additionalNode_CH
Appears in collections:Publikationen Gesundheit

Files in This Item:
There are no files associated with this item.
Show simple item record
Zhao, W. H., Zhang, L. X., Liu, C. X., Niedermann Schneider, K., Yang, H. Z., & Luo, W. (2019). Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis. Clinical Rheumatology, 38(8), 2119–2127. https://doi.org/10.1007/s10067-019-04510-8
Zhao, W.H. et al. (2019) ‘Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis’, Clinical Rheumatology, 38(8), pp. 2119–2127. Available at: https://doi.org/10.1007/s10067-019-04510-8.
W. H. Zhao, L. X. Zhang, C. X. Liu, K. Niedermann Schneider, H. Z. Yang, and W. Luo, “Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis,” Clinical Rheumatology, vol. 38, no. 8, pp. 2119–2127, 2019, doi: 10.1007/s10067-019-04510-8.
ZHAO, Wen H., Li X. ZHANG, Chan X. LIU, Karin NIEDERMANN SCHNEIDER, Han Z. YANG und Wen LUO, 2019. Validation of the Chinese version of joint protection self-efficacy scale in patients with rheumatoid arthritis. Clinical Rheumatology. 2019. Bd. 38, Nr. 8, S. 2119–2127. DOI 10.1007/s10067-019-04510-8
Zhao, Wen H., Li X. Zhang, Chan X. Liu, Karin Niedermann Schneider, Han Z. Yang, and Wen Luo. 2019. “Validation of the Chinese Version of Joint Protection Self-Efficacy Scale in Patients with Rheumatoid Arthritis.” Clinical Rheumatology 38 (8): 2119–27. https://doi.org/10.1007/s10067-019-04510-8.
Zhao, Wen H., et al. “Validation of the Chinese Version of Joint Protection Self-Efficacy Scale in Patients with Rheumatoid Arthritis.” Clinical Rheumatology, vol. 38, no. 8, 2019, pp. 2119–27, https://doi.org/10.1007/s10067-019-04510-8.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.